Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSUPD.L Regulatory News (SUPD)

  • There is currently no data for SUPD

3rd Quarter Results

13 Nov 2020 07:35

RNS Number : 2472F
Sunplus Technology Co Limited
13 November 2020
 

Sunplus Technology Company Limited

Consolidated Balance Sheets

Ended September 30, 2020*

(In Thousands of New Taiwan Dollars)

 

Assets

Amount

Liabilities & Shareholders Equity

Amount

Cash & Equivalent

3,284,620

Current Liabilities

1,670,464

Financial assets at fair value through profit or loss-current

582,232

Non-Current Liabilities

778,629

Accounts & Notes receivable

1,219,582

Total Liabilities

2,449,093

Other Receivable

23,956

Equity attributable to owners of the parent

Inventories

935,227

Capital stock

5,919,949

Other current assets

237,701

Shares to be issued

Total Current Assets

6,283,318

Capital surplus

496,874

Appropriated as legal reserve

1,712,390

Financial assets at fair value through profit or loss - non-current

1,077,619

Appropriated as special reserve

276,189

Financial assets at fair value through other comprehensive income - non-current

183,124

Unappropriated earnings (deficit)

131,141

Investments accounted for using the equity method

712,170

Others

(310,584)

Property, plant and equipment

1,972,524

Treasury Stock

(63,401)

Right-of-use asset

231,797

Total equity attributable to owners of the parent

8,162,558

Investment properties

1,008,415

Intangible Assets-Net

321,675

Non-Controlling Interests

1,490,113

Deferred tax assets

30,084

Total Shareholders¡¦ Equity

9,652,671

Net defined benefit asset, non-current

1,163

Other Non-Current Assets

279,875

Total Non-Current Assets

5,818,446

Total Assets

12,101,764

Total Liabilities & Shareholders' Equity

12,101,764

 

Sunplus Technology Company Limited

Consolidated Statements of Income

From January 1 to September 30, 2020 and 2019

(In Thousands of New Taiwan Dollars, Except Earnings per share) 

Unit: NT$K, Except EPS

2020

2019

YoY

Net sales

4,586,008

4,188,646

9.49

Cost

2,489,269

2,379,656

4.61

Gross Profit

2,096,739

1,808,990

15.91

Marketing Expense

255,797

209,424

22.14

General& Administrative Expense

352,728

372,162

(5.22)

R&D Expenses

1,174,949

1,122,046

4.71

Expected credit (gain) loss

(51)

183

(127.87)

Other operating income(Expense)

116

116

-

Total operating income (expense)

313,432

105,291

197.68

Total non-operating income (expense)

126,935

97,498

30.19

Income(loss) before income tax from continued operating units

440,367

202,789

117.16

Income tax expense

112,439

52,755

113.13

Consolidated Net Income(loss)

327,928

150,034

118.57

Consolidated Net Income(loss)Attributable To Shareholders of the parent

132,496

14,717

800.29

Consolidated Earnings Per Share NT$ Attributable To Shareholders of the parent*

$0.23

$0.03

* Based on outstanding 588,434,923 shares on 2020/09/30

Sunplus Technology Company Limited

Consolidated Cash Flow Summary

From January 1 to September 30, 2020 and 2019

(In Thousand New Taiwan Dollars)

 

ITEM

2020

2019

Cash Flow in (out) from operating

302,837

252,266

Cash Flow in (out) from Investing

(21,274)

(20,046)

Cash Flow in (out) from Financing

(9,969)

(606,088)

Impact from Fx Change

(7,602)

2,268

Net Increase (Decrease) in Cash & Cash Equivalents

263,992

(371,600)

Cash & Cash Equivalents, Beginning of Period

3,020,628

3,235,721

Cash & Cash Equivalents, End of Period

3,284,620

2,864,121

 

 

Spokesman

Wayne Shen

Tel: +886-3-5786005 ext. 2350

E-mail: wayne@sunplus.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRTFZMMMNFZGGZG
Date   Source Headline
13th Oct 20228:00 amRNSCancellation - Sunplus Technology Co Ld
13th Oct 20228:00 amRNSRemoval- Sunplus Technology Co. Ltd
11th Oct 20229:55 amRNSAnnouncement re: Rights Issue
12th Aug 202211:35 amRNSResult of Meeting
12th Aug 202211:25 amRNSHalf-year Report
13th May 20229:21 amRNS1st Quarter Results
29th Mar 20221:18 pmRNSFinal Results
12th Nov 202110:13 amRNS3rd Quarter Results
13th Aug 202111:51 amRNSHalf-year Report
14th May 202111:38 amRNS1st Quarter Results
29th Mar 20219:19 amRNSFinal Results
13th Nov 20207:35 amRNS3rd Quarter Results
14th Aug 20207:50 amRNSHalf-year Report
14th May 202011:28 amRNS1st Quarter Results
31st Mar 20207:00 amRNSFinal Results
13th Nov 201910:08 amRNS3rd Quarter Results
13th Aug 201911:16 amRNSHalf-year Report
13th May 201912:08 pmRNS1st Quarter Results
20th Mar 20199:51 amRNSFinal Results
12th Nov 201812:00 pmRNS3rd Quarter Results
9th Aug 20187:51 amRNSHalf-year Report - Replacement
8th Aug 201812:00 pmRNSHalf-year Report
14th May 201812:20 pmRNS1st Quarter Results
14th Mar 201812:00 pmRNSFinal Results
8th Nov 201711:00 amRNS3rd Quarter Results
10th Aug 20177:00 amRNSHalf-year Report
10th May 20171:00 pmRNS1st Quarter Results
16th Mar 20177:00 amRNSFinal Results
16th Mar 20177:00 amRNSNotice of AGM
14th Nov 20169:02 amRNS3rd Quarter Results
10th Aug 201610:00 amRNSHalf-year Report
11th May 201610:00 amRNS1st Quarter Results
23rd Mar 201610:00 amRNSAGM2016& NT$0.89/Share Cash Dividend Proposed
23rd Mar 201610:00 amRNSAnnual Financial Report
11th Nov 201510:00 amRNS3rd Quarter Results
12th Aug 201510:00 amRNSHalf Yearly Report
12th Jun 20157:00 amRNSAGM Statement
14th May 201510:00 amRNS1st Quarter Results
22nd Apr 201510:00 amRNSDividend Declaration
23rd Mar 201510:00 amRNSAGM Statement
23rd Mar 201510:00 amRNSAnnual Financial Report
14th Nov 201411:00 amRNS3rd Quarter Results
11th Jun 201411:30 amRNSResult of AGM
14th May 201410:49 amRNS1st Quarter Results
24th Mar 201412:00 pmRNSNotice of AGM
24th Mar 201412:00 pmRNSFinal Results
13th Nov 201310:30 amRNS3rd Quarter Results
17th Dec 201210:00 amRNSRe Joint Venture
30th Oct 201212:00 pmRNS3rd Quarter Results
17th Aug 20127:00 amRNSHalf Yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.